Header cover image

Swiss (SMI) Healthcare Sector Analysis

UpdatedApr 23, 2025
DataAggregated Company Financials
Companies35
  • 7D0.02%
  • 3M-7.5%
  • 1Y2.9%
  • YTD-2.6%

Over the last 7 days, the Healthcare industry has remained flat. In line with that, the industry has also been flat over the past 12 months. Earnings are forecast to grow by 13% annually.

Sector Valuation and Performance

Has the Swiss Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 23 Apr 2025CHF 546.0bCHF 150.0bCHF 21.8b25.9x25.1x3.6x
Fri, 21 Mar 2025CHF 630.3bCHF 154.9bCHF 22.4b31.2x28.1x4.1x
Sun, 16 Feb 2025CHF 628.8bCHF 155.5bCHF 22.3b30.1x28.2x4x
Tue, 14 Jan 2025CHF 584.3bCHF 153.7bCHF 24.7b29.9x23.7x3.8x
Thu, 12 Dec 2024CHF 566.3bCHF 151.0bCHF 24.2b28.9x23.4x3.8x
Sat, 09 Nov 2024CHF 589.6bCHF 150.2bCHF 24.1b29.8x24.4x3.9x
Mon, 07 Oct 2024CHF 598.9bCHF 148.0bCHF 22.5b32.9x26.6x4x
Wed, 04 Sep 2024CHF 622.9bCHF 147.3bCHF 22.4b32.6x27.9x4.2x
Fri, 02 Aug 2024CHF 619.6bCHF 148.9bCHF 22.5b31.8x27.5x4.2x
Sun, 30 Jun 2024CHF 575.8bCHF 149.0bCHF 22.7b35.5x25.3x3.9x
Tue, 28 May 2024CHF 558.6bCHF 150.2bCHF 22.9b33.7x24.4x3.7x
Thu, 25 Apr 2024CHF 537.6bCHF 146.2bCHF 22.9b35.3x23.5x3.7x
Sat, 23 Mar 2024CHF 534.6bCHF 144.2bCHF 22.2b37.5x24x3.7x
Mon, 19 Feb 2024CHF 520.7bCHF 142.8bCHF 22.4b32.9x23.3x3.6x
Wed, 17 Jan 2024CHF 544.3bCHF 152.1bCHF 21.9b27.3x24.9x3.6x
Fri, 15 Dec 2023CHF 524.3bCHF 152.2bCHF 21.9b27.1x24x3.4x
Sun, 12 Nov 2023CHF 502.6bCHF 155.0bCHF 22.2b23.4x22.7x3.2x
Tue, 10 Oct 2023CHF 532.7bCHF 154.2bCHF 21.7b28.2x24.5x3.5x
Thu, 07 Sep 2023CHF 535.2bCHF 144.7bCHF 21.2b30x25.3x3.7x
Sat, 05 Aug 2023CHF 549.4bCHF 146.5bCHF 22.5b35.3x24.4x3.8x
Mon, 03 Jul 2023CHF 565.9bCHF 147.1bCHF 22.2b35.6x25.5x3.8x
Wed, 31 May 2023CHF 571.6bCHF 147.7bCHF 22.3b34.7x25.6x3.9x
Fri, 28 Apr 2023CHF 568.7bCHF 147.0bCHF 22.4b32x25.4x3.9x
Sun, 26 Mar 2023CHF 528.4bCHF 148.0bCHF 22.5b36.3x23.5x3.6x
Tue, 21 Feb 2023CHF 548.4bCHF 147.8bCHF 22.7b32.5x24.1x3.7x
Thu, 19 Jan 2023CHF 573.2bCHF 147.8bCHF 37.8b32.5x15.2x3.9x
Sat, 17 Dec 2022CHF 565.9bCHF 148.9bCHF 38.2b30.4x14.8x3.8x
Mon, 14 Nov 2022CHF 584.0bCHF 149.5bCHF 38.4b30.8x15.2x3.9x
Wed, 12 Oct 2022CHF 562.6bCHF 153.1bCHF 40.7b26.7x13.8x3.7x
Fri, 09 Sep 2022CHF 582.4bCHF 151.4bCHF 40.1b25.7x14.5x3.8x
Sun, 07 Aug 2022CHF 600.8bCHF 150.2bCHF 39.9b31.6x15.1x4x
Tue, 05 Jul 2022CHF 590.6bCHF 148.7bCHF 40.4b30.2x14.6x4x
Thu, 02 Jun 2022CHF 608.0bCHF 148.9bCHF 40.4b31.1x15x4.1x
Sat, 30 Apr 2022CHF 647.2bCHF 148.8bCHF 40.4b37.4x16x4.4x
Price to Earnings Ratio

16x


Total Market Cap: CHF 647.2bTotal Earnings: CHF 40.4bTotal Revenue: CHF 148.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Healthcare Sector Price to Earnings3Y Average 22.4x202320242025
Current Industry PE
  • Investors are optimistic on the Swiss Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 25.1x which is higher than its 3-year average PE of 22.4x.
  • The industry is trading close to its 3-year average PS ratio of 3.8x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 19% per year over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Swiss Healthcare sector?

CH Market0.14%
Healthcare0.021%
Life Sciences1.06%
Healthcare Services0.41%
Medical Equipment0.30%
Pharma-0.15%
Biotech-2.32%
Healthtech-7.55%
Industry PE
  • Investors are most optimistic about the Life Sciences industry, which is trading close to its 3-year average PE ratio of 44.8x.
    • Analysts expect its future annual earnings growth (20.1%) to be largely in line with prior year's earnings growth.
  • Investors are most pessimistic about the Pharma industry, although it looks like investor sentiment has improved given that it's trading above its 3-year average of 19.4x.
Forecasted Growth
  • Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 35% over the next 5 years.
  • This is better than its past earnings decline of 79% per year.
  • In contrast, the Biotech industry is expected to see its earnings decline by 9.5% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ROG Roche HoldingCHF 258.101.5%
+CHF 2.9b
16.2%PE24.8x
LONN Lonza GroupCHF 562.003.8%
+CHF 1.4b
7.5%PE62.4x
ALC AlconCHF 77.942.9%
+CHF 1.1b
7.1%PE46x
NOVN NovartisCHF 90.900.5%
+CHF 834.9m
2.0%PE17.5x
STMN Straumann HoldingCHF 99.744.4%
+CHF 676.1m
-27.3%PE34.8x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

SANN

CHF 14.54

Santhera Pharmaceuticals Holding

7D

-1.0%

1Y

53.7%

KURN

CHF 21.92

Kuros Biosciences

7D

-0.3%

1Y

225.7%

ASCN

CHF 3.00

Ascom Holding

7D

-3.5%

1Y

-59.5%

COPN

CHF 46.50

Cosmo Pharmaceuticals

7D

-2.5%

1Y

-38.2%

GALD

CHF 80.60

Galderma Group

7D

2.9%

1Y

21.2%

SFZN

CHF 916.00

Siegfried Holding

7D

3.4%

1Y

4.4%

GALE

CHF 82.50

Galenica

7D

-0.9%

1Y

16.1%

VBSN

CHF 155.00

IVF Hartmann Holding

7D

-1.9%

1Y

7.6%

STMN

CHF 99.74

Straumann Holding

7D

4.4%

1Y

-27.3%

ROG

CHF 258.10

Roche Holding

7D

1.5%

1Y

16.2%

LONN

CHF 562.00

Lonza Group

7D

3.8%

1Y

7.5%

AEVS

CHF 13.35

Aevis Victoria

7D

-1.8%

1Y

-4.0%

NOVN

CHF 90.90

Novartis

7D

0.5%

1Y

2.0%